Allergy group ALK is continuing its hunt for assets to strengthen its future product portfolio.
At the start of the year, ALK collaborated with US-based X-Chem to develop the allergy drugs of tomorrow.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.